Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Wong Mito Lab, |
RCV000499583 | SCV000598328 | uncertain significance | Mitochondrial DNA depletion syndrome 13 | 2017-08-10 | criteria provided, single submitter | reference population | The NM_012160.4:c.737T>C (NP_036292.2:p.Ile246Thr) [GRCH38: NC_000006.12:g.98917495A>G] variant in FBXL4 gene is interpretated to be a Uncertain Significance - Conflicting Evidence based on ACMG guidelines (PMID: 25741868). This variant meets one or more of the following evidence codes reported in the ACMG-guideline. PM2:This variant is absent in key population databases. BP4:Computational evidence/predictors indicate no impact on the FBXL4 structure, function, or protein-protein interaction. Based on this evidence code ClinGen Pathogenicity Calculator (PMID:28081714) suggested that the variant is Uncertain Significance - Conflicting Evidence. |
Baylor Genetics | RCV000499583 | SCV001519807 | uncertain significance | Mitochondrial DNA depletion syndrome 13 | 2019-05-03 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV000676936 | SCV002325238 | likely benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000676936 | SCV004032691 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | FBXL4: BP4 |
Gene |
RCV000676936 | SCV005078235 | uncertain significance | not provided | 2024-03-04 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Mayo Clinic Laboratories, |
RCV000676936 | SCV000802755 | uncertain significance | not provided | 2016-02-29 | no assertion criteria provided | clinical testing |